GlassScriptPhysician profile
William French
NPI 1356906283
$4,157.52
in general payments reported to CMS, 2019-2025
27 companies · $3,682 in 2025
The $3,682 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.66 · 2022: $78.18 · 2023: $13.75 · 2024: $369 · 2025: $3,682.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,850 · Travel and Lodging: $1,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,850.12 |
| Travel and Lodging | $1,214.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,665.98 | 2024-2025 | Lumenis Pulse 120h, Axonics, Ams 800 Artificial Urinary Sphincter |
| Sumitomo Pharma America, INC. | $572.69 | 2024-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $275.31 | 2025 | |
| Dendreon Pharmaceuticals LLC | $209.75 | 2024-2025 | Provenge |
| Janssen Biotech, INC. | $205.99 | 2024-2025 | Erleada, Akeega, Balversa |
| Immunitybio, INC. | $150.33 | 2025 | |
| Abbvie INC. | $145.37 | 2025 | |
| Calyxo, INC. | $145.33 | 2025 | Cvac Aspiration System |
| Urogen Pharma, INC. | $136.84 | 2025 | |
| Photocure INC | $131.80 | 2025 | Cysview |
| Progenics Pharmaceuticals, INC. | $69.51 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $55.81 | 2025 | Welireg, Keytruda, Keytruda Qlex |
| Myovant Sciences INC. | $44.38 | 2022 | |
| Ferring Pharmaceuticals INC. | $43.48 | 2025 | Adstiladrin |
| Laborie Medical Technologies Corp. | $37.54 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $34.39 | 2025 | Posluma |
| Teleflex LLC | $33.64 | 2025 | Barrigel |
| Telix Pharmaceuticals | $29.57 | 2025 | Illuccix |
| Tolmar, INC. | $28.41 | 2025 | Eligard, Jatenzo |
| Olympus America INC. | $28.41 | 2021-2023 | Cysto-Nephro Videoscope, Hd Camera Head |
| Procept Biorobotics Corporation | $21.17 | 2025 | |
| Amgen INC. | $19.70 | 2022 | |
| Provepharm INC. | $19.51 | 2025 | Bludigo |
| Accord Healthcare, INC. | $19.34 | 2025 | |
| Azurity Pharmaceuticals, INC. | $16.00 | 2025 | Azmiro |
| Rti Surgical, INC | $12.23 | 2025 | |
| Valencia Technologies Corporation | $5.04 | 2025 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William French listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.